Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment

Glycosphingolipid expression differs between human breast cancer stem cells (CSC) and cancer non-stem cells (non-CSC). We performed studies of viability, type of cell death, cancer stem cell percent and glycosphingolipid expression on CSC and non-CSC after treatment of MDA-MB-231 and MDA-MB-453 trip...

Descripción completa

Detalles Bibliográficos
Autores principales: Marijan, Sandra, Markotić, Anita, Mastelić, Angela, Režić-Mužinić, Nikolina, Pilkington, Lisa Ivy, Reynisson, Johannes, Čulić, Vedrana Čikeš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368022/
https://www.ncbi.nlm.nih.gov/pubmed/32680999
http://dx.doi.org/10.1038/s41598-020-68516-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368022/
https://www.ncbi.nlm.nih.gov/pubmed/32680999
http://dx.doi.org/10.1038/s41598-020-68516-y

Ejemplares similares